LIV-021

N/A

Report date: 2024/11/27 15:02:54

Base Information

Drug NameLIV-021
Drug Alias NameLIV-021LIV021
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionImmunomodulatorsBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLiveome Inc
China Registration ClassN/A

Develop Information

Active CompaniesLiveome Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A